Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Porin A (PorA) is a major outer membrane protein of Neisseria meningitidis, functioning as a cation-selective pore that facilitates the passive diffusion of small hydrophilic molecules across the bacterial outer membrane [1]. Structurally, it is a 16-stranded beta-barrel protein characterized by eight extracellular loops, with loops 1 and 4 being highly variable and serving as the primary targets for neutralizing antibodies [2]. In Neisseria meningitidis serogroup B, PorA is a significant therapeutic target because it induces a robust serum bactericidal antibody response, which is the established correlate of protection against invasive meningococcal disease [3]. Despite its immunogenicity, the high sequence diversity of the PorA loops poses a significant challenge for vaccine development, as immunity is often restricted to specific strains [4]. PorA is a central component of outer membrane vesicle (OMV) vaccines and is included in the multicomponent vaccine Bexsero to provide protection against specific serogroup B strains [5]. Its role in bacterial fitness and its accessibility on the cell surface make it a focal point for both diagnostic subtyping and preventative immunotherapy [1, 3]. Citations: [1] UniProt (P05022); [2] Massari et al. (2003), The Role of Porins in Neisseria meningitidis Pathogenicity; [3] Holst et al. (2009), Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis; [4] Sacchi et al. (1998), Sequence diversity of PorA from Neisseria meningitidis; [5] Gossger et al. (2012), Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine.
Induction of host serum bactericidal antibodies that facilitate complement-mediated killing of the pathogen [3].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Porin A outer-membrane protein (PorA).